2m 2m 2m 2m 2m 2m 2m
Bioline RX Sp ADR (BLRX)
NASDAQ
$3.32+$0.06 (+1.69%)
Price as of Jun 23, 2026 6:32 PM EDT- $14.1MMarket Cap
- -26.58%1-Year Change
- BiotechnologyIndustry
Bioline RX Sp ADR (BLRX)
$3.32+$0.06 (+1.69%)
BLRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.26 | ||
Change | +$0.02 (+0.62%) | ||
Open | $3.23 | ||
High | $3.45 | ||
Low | $3.23 | ||
Previous Close | $3.24 | ||
Volume | 74,173 | ||
30-Day Average Volume | 35,232 | ||
1-Week Change | 6.89% | ||
1-Month Change | 6.54% | ||
1-Year Change | -26.58% | ||
3-Year Change | -95.02% | ||
5-Year Change | -96.98% | ||
Fundamentals | |||
Shares Outstanding | 4.4M | ||
Total Assets | $40.9M | ||
Market Cap | $14.1M | ||
Enterprise Value | $10.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 01/30/2025 | ||
Earnings & Revenue